-Source-Salon- On Friday the Financial Times reported that billionaire pharmaceutical tycoon Richard Sackler has secured a patent for a new drug to treat opioid addiction. The drug a reformulation of buprenorphine is essentially just a milder opioid that can blunt the symptoms of withdrawal while a person is being weaned off competing variants of which are already generating nearly $900 million in U.S. sales. Sacklers family also happens to own Purdue Pharma the company that first developed OxyContin a powerful narcotic painkiller that has been blamed for spurring the epidemic of opioid addiction that has decimated communities all across America. In other words Sackler made millions off of sales of a drug that caused a massive public health crisis and now he stands to make millions more by selling the public a solution. Purdue one of several drug companies that made a decades-long push for liberal prescription of opioids is currently facing a mountain of lawsuits. Prosecutors in several states allege Purdue was aware of the risk of addiction and overdose but deceived doctors and patients and downplayed the risks to increase their sales a charge the company denies. Massachusetts Attorney General Maura Healey directly names several members of the Sackler family as defendants.
N/A by N/A is licensed under N/A N/A
©2020, The American Dossier. All rights reserved. Privacy Policy